Lymphocyte to C-Reactive Protein Ratio as an Early Biomarker to Distinguish Sepsis from Pneumonia in Neonates

References

• Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60:367–389. doi:10.1016/j.pcl.2012.12.003
   PubMed Web of Science ®Google Scholar
• Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6:223–230. doi:10.1016/s2213-2600(18)30063-8
   PubMed Web of Science ®Google Scholar
• Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46:10–67. doi:10.1007/s00134-019-05878-6
   PubMed Web of Science ®Google Scholar
• Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–1780. doi:10.1016/s0140-6736(17)31002-4
   PubMed Web of Science ®Google Scholar
• Grossman Z, Paul WE. Dynamic tuning of lymphocytes: physiological basis, mechanisms, and function. Annu Rev Immunol. 2015;33:677–713. doi:10.1146/annurev-immunol-032712-100027
   PubMed Web of Science ®Google Scholar
• Mastrogiovanni M, Di Bartolo V, Alcover A. Cell polarity regulators, multifunctional organizers of lymphocyte activation and function. Biomed J. 2022;45:299–309. doi:10.1016/j.bj.2021.10.002
   PubMed Web of Science ®Google Scholar
• Le Tulzo Y, Pangault C, Gacouin A, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002;18:487–494. doi:10.1097/00024382-200212000-00001
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol. 2005;174:5110–5118. doi:10.4049/jimmunol.174.8.5110
   PubMed Web of Science ®Google Scholar
• Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, Green JM. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care. 2012;16:R112. doi:10.1186/cc11404
   PubMed Web of Science ®Google Scholar
• Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42(5):383–391. doi:10.1097/SHK.0000000000000234
   PubMed Web of Science ®Google Scholar
• Chung KP, Chang HT, Lo SC, et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock. 2015;43(6):569–575. doi:10.1097/SHK.0000000000000347
   PubMed Web of Science ®Google Scholar
• Sheikh Motahar Vahedi H, Bagheri A, Jahanshir A, Seyedhosseini J, Vahidi E. Association of lymphopenia with short term outcomes of sepsis patients; a brief report. Arch Acad Emerg Med. 2019;7(1):e14.
   PubMedGoogle Scholar
• Jiang J, Du H, Su Y, et al. Nonviral infection-related lymphocytopenia for the prediction of adult sepsis and its persistence indicates a higher mortality. Medicine. 2019;98(29):e16535. doi:10.1097/MD.0000000000016535
   PubMed Web of Science ®Google Scholar
• Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004;279(47):48487–48490. doi:10.1074/jbc.R400025200
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
   PubMed Web of Science ®Google Scholar
• Stocker M, van Herk W, El Helou S, et al. C-reactive protein, procalcitonin, and white blood count to rule out neonatal early-onset sepsis within 36 hours: a secondary analysis of the neonatal procalcitonin intervention study. Clin Infect Dis. 2021;73(2):e383–e390. doi:10.1093/cid/ciaa876
   PubMed Web of Science ®Google Scholar
• Wang HE, Shapiro NI, Safford MM, et al. High-sensitivity C-reactive protein and risk of sepsis. PLoS One. 2013;8(7):e69232. doi:10.1371/journal.pone.0069232
   PubMed Web of Science ®Google Scholar
• Tonduangu N, Le Borgne P, Lefebvre F, et al. Prognostic value of C-Reactive Protein to Lymphocyte Ratio (CLR) in emergency department patients with SARS-CoV-2 infection. J Pers Med. 2021;12(1):11. doi:10.3390/jpm11121274
   PubMedGoogle Scholar
• Ullah W, Basyal B, Tariq S, et al. Lymphocyte-to-C-reactive protein ratio: a novel predictor of adverse outcomes in COVID-19. J Clin Med Res. 2020;12(7):415–422. doi:10.14740/jocmr4227
   PubMedGoogle Scholar
• Li X, Wei Y, Xu Z, et al. Lymphocyte-to-C-reactive protein ratio as an early sepsis biomarker for neonates with suspected sepsis. Mediators Inflamm. 2023;2023:9077787. doi:10.1155/2023/9077787
   PubMed Web of Science ®Google Scholar
• Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8. doi:10.1097/01.Pcc.0000149131.72248.E6
   PubMedGoogle Scholar
• Wynn JL, Polin RA. A neonatal sequential organ failure assessment score predicts mortality to late-onset sepsis in preterm very low birth weight infants. Pediatr Res. 2020;88:85–90. doi:10.1038/s41390-019-0517-2
   PubMed Web of Science ®Google Scholar
• Hughes G. Youden’s index and the weight of evidence. Methods Inf Med. 2015;54:198–199. doi:10.3414/ME14-04-0003
   PubMed Web of Science ®Google Scholar
• Molloy EJ, Bearer CF. Paediatric and neonatal sepsis and inflammation. Pediatr Res. 2022;91:267–269. doi:10.1038/s41390-021-01918-4
   PubMed Web of Science ®Google Scholar
• Celik IH, Hanna M, Canpolat FE, Mohan P. Diagnosis of neonatal sepsis: the past, present and future. Pediatr Res. 2022;91:337–350. doi:10.1038/s41390-021-01696-z
   PubMed Web of Science ®Google Scholar
• Oza S, Lawn JE, Hogan DR, Mathers C, Cousens SN. Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000–2013. Bull World Health Organ. 2015;93:19–28. doi:10.2471/BLT.14.139790
   PubMed Web of Science ®Google Scholar
• Iroh Tam PY, Bendel CM. Diagnostics for neonatal sepsis: current approaches and future directions. Pediatr Res. 2017;82:574–583. doi:10.1038/pr.2017.134
   PubMed Web of Science ®Google Scholar
• Fleisher TA, Rosenzweig SD. Lymphocyte reference intervals in the era of newborn screening. J Allergy Clin Immunol. 2019;144:1516–1517. doi:10.1016/j.jaci.2019.09.022
   PubMed Web of Science ®Google Scholar
• Ochoa JB, Makarenkova V. T lymphocytes. Crit Care Med. 2005;33:S510–S513. doi:10.1097/01.ccm.0000186788.71460.53
   PubMed Web of Science ®Google Scholar
• Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--An updated view. Mediators Inflamm. 2013;2013:165974. doi:10.1155/2013/165974
   PubMed Web of Science ®Google Scholar
• Monneret G, Venet F. A rapidly progressing lymphocyte exhaustion after severe sepsis. Crit Care. 2012;16:140. doi:10.1186/cc11416
   PubMed Web of Science ®Google Scholar
• Li T, Qi M, Dong G, et al. Clinical value of prognostic nutritional index in prediction of the presence and severity of neonatal sepsis. J Inflamm Res. 2021;14:7181–7190. doi:10.2147/JIR.S343992
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Peroni HJ, Gabarrus A, et al. Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis. Open Forum Infect Dis. 2021;8:ofab169. doi:10.1093/ofid/ofab169
   PubMed Web of Science ®Google Scholar
• Muszynski JA, Nofziger R, Greathouse K, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care. 2014;18:R145. doi:10.1186/cc13980
   PubMed Web of Science ®Google Scholar
• Finfer S, Venkatesh B, Hotchkiss RS, Sasson SC. Lymphopenia in sepsis-an acquired immunodeficiency? Immunol Cell Biol. 2022;101(6):535–544. doi:10.1111/imcb.12611
   PubMed Web of Science ®Google Scholar
• Angin YS, Yildirim M, Dasiran F, Okan I. Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer? ANZ J Surg. 2021;91:1521–1527. doi:10.1111/ans.16913
   PubMed Web of Science ®Google Scholar
• Iseda N, Itoh S, Yoshizumi T, et al. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma. Int J Clin Oncol. 2021;26:1890–1900. doi:10.1007/s10147-021-01985-x
   PubMed Web of Science ®Google Scholar
• Yildirim M, Koca B. Lymphocyte C-reactive protein ratio: a new biomarker to predict early complications after gastrointestinal oncologic surgery. Cancer Biomark. 2021;31:409–417. doi:10.3233/CBM-210251
   PubMed Web of Science ®Google Scholar
• Aoyama T, Nakazano M, Nagasawa S, et al. The association of the Lymphocyte-to-C-Reactive-Protein Ratio with gastric cancer patients who receive curative treatment. In Vivo. 2022;36:482–489. doi:10.21873/invivo.12728
   PubMed Web of Science ®Google Scholar
• Utsumi M, Inagaki M, Kitada K, et al. Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgery. Ann Surg Treat Res. 2022;103:72–80. doi:10.4174/astr.2022.103.2.72
   PubMed Web of Science ®Google Scholar
• Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020;92:1733–1734. doi:10.1002/jmv.25819
   PubMed Web of Science ®Google Scholar
• Demirkol ME, Bilgin S, Kahveci G, et al. C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study. Cir Cir. 2022;90:596–601. doi:10.24875/CIRU.22000124
   PubMed Web of Science ®Google Scholar
• Yang M, Chen X, Xu Y. A retrospective study of the C-reactive protein to lymphocyte ratio and disease severity in 108 patients with early COVID-19 pneumonia from January to March 2020 in Wuhan, China. Med Sci Monit. 2020;26:e926393. doi:10.12659/MSM.926393
   PubMed Web of Science ®Google Scholar